WallStreetZenWallStreetZen

NASDAQ: OLMA
Olema Pharmaceuticals Inc Stock Ownership - Who owns Olema Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Olema Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Andrew RappaportDirector2025-11-2135,868$0.39
$13.99kBuy
Cyrus HarmonDirector2025-09-1810,000$8.33
$83.30kSell
Cyrus HarmonDirector2025-09-183,086$8.32
$25.68kSell
Cyrus HarmonDirector2025-09-1610,000$8.04
$80.40kSell
Cyrus HarmonDirector2025-09-161,914$8.08
$15.47kSell
Bain Capital Life Sciences Investors LLC10% Owner2025-01-08300,000$5.76
$1.73MBuy
G. Walmsley GrahamDirector2024-12-17700,761$6.75
$4.73MBuy
G. Walmsley GrahamDirector2024-12-17700,761$6.75
$4.73MSell
Naseem ZojwallaCHIEF MEDICAL OFFICER2024-12-1614,000$4.87
$68.18kBuy

1 of 1

OLMA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when OLMA insiders and whales buy or sell their stock.

OLMA Shareholders

What type of owners hold Olema Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bain Capital Life Sciences Investors LLC10.92%7,500,000$247.88MInsider
Bain Capital Life Sciences Investors LLC9.97%6,843,954$226.19MInstitution
Paradigm Biocapital Advisors LP9.90%6,794,172$224.55MInstitution
Paradigm Biocapital Advisors LP8.02%5,503,600$181.89MInsider
Bvf Inc7.71%5,295,893$175.03MInstitution
Blackrock Inc6.88%4,726,394$156.21MInstitution
Janus Henderson Group PLC5.22%3,585,849$118.51MInstitution
Deep Track Capital LP5.05%3,470,172$114.69MInstitution
Cormorant Asset Management LP4.76%3,270,544$108.09MInsider
Logos Global Management LP4.67%3,208,875$106.05MInstitution

1 of 3

OLMA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OLMA72.63%27.37%Net BuyingNet Buying
SRPT74.30%25.70%Net SellingNet Selling
RXRX62.25%13.34%Net SellingNet Selling
MESO0.28%0.00%
IBRX14.52%7.76%Net Selling
View Top Biotech Stocks

Olema Pharmaceuticals Stock Ownership FAQ

Who owns Olema Pharmaceuticals?

Olema Pharmaceuticals (NASDAQ: OLMA) is owned by 99.45% institutional shareholders, 37.48% Olema Pharmaceuticals insiders, and 0.00% retail investors. Bain Capital Life Sciences Investors LLC is the largest individual Olema Pharmaceuticals shareholder, owning 7.50M shares representing 10.92% of the company. Bain Capital Life Sciences Investors LLC's Olema Pharmaceuticals shares are currently valued at $247.87M.

If you're new to stock investing, here's how to buy Olema Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.